Ai‐Hong Yang

1.0k total citations
58 papers, 863 citations indexed

About

Ai‐Hong Yang is a scholar working on Pharmacology, Organic Chemistry and Electronic, Optical and Magnetic Materials. According to data from OpenAlex, Ai‐Hong Yang has authored 58 papers receiving a total of 863 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pharmacology, 17 papers in Organic Chemistry and 17 papers in Electronic, Optical and Magnetic Materials. Recurrent topics in Ai‐Hong Yang's work include Magnetism in coordination complexes (17 papers), Metal-Organic Frameworks: Synthesis and Applications (16 papers) and Computational Drug Discovery Methods (15 papers). Ai‐Hong Yang is often cited by papers focused on Magnetism in coordination complexes (17 papers), Metal-Organic Frameworks: Synthesis and Applications (16 papers) and Computational Drug Discovery Methods (15 papers). Ai‐Hong Yang collaborates with scholars based in China, Hong Kong and Spain. Ai‐Hong Yang's co-authors include Hong‐Ling Gao, Xiaodi Kou, Rui Shen, Jian‐Zhong Cui, Xin He, Hui Ju, Bin Zhao, Lili Wang, Wei Shi and Fangliang Zhang and has published in prestigious journals such as Inorganic Chemistry, Analytica Chimica Acta and International Journal of Pharmaceutics.

In The Last Decade

Ai‐Hong Yang

55 papers receiving 860 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ai‐Hong Yang China 19 268 200 195 189 173 58 863
Mahalaxmi Mohan India 22 197 0.7× 131 0.7× 86 0.4× 311 1.6× 143 0.8× 81 1.2k
Yongmei Pan United States 19 181 0.7× 35 0.2× 334 1.7× 140 0.7× 162 0.9× 24 1.1k
Ying Dong Canada 24 125 0.5× 44 0.2× 312 1.6× 704 3.7× 88 0.5× 57 1.4k
Fatih Sönmez Türkiye 22 108 0.4× 226 1.1× 296 1.5× 882 4.7× 98 0.6× 72 1.5k
Magdalena Małecka Poland 20 233 0.9× 96 0.5× 160 0.8× 695 3.7× 181 1.0× 93 1.2k
Ján Vančo Czechia 24 428 1.6× 279 1.4× 113 0.6× 915 4.8× 303 1.8× 91 1.9k
Ming‐Jin Xie China 21 413 1.5× 123 0.6× 141 0.7× 386 2.0× 195 1.1× 85 1.2k
Jean‐Pierre Catteau France 18 137 0.5× 83 0.4× 95 0.5× 578 3.1× 118 0.7× 30 1.3k
Xiaodi Kou China 14 85 0.3× 34 0.2× 157 0.8× 212 1.1× 69 0.4× 27 490
Dieter Ströhl Germany 21 135 0.5× 49 0.2× 112 0.6× 547 2.9× 71 0.4× 70 1.1k

Countries citing papers authored by Ai‐Hong Yang

Since Specialization
Citations

This map shows the geographic impact of Ai‐Hong Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ai‐Hong Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ai‐Hong Yang more than expected).

Fields of papers citing papers by Ai‐Hong Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ai‐Hong Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ai‐Hong Yang. The network helps show where Ai‐Hong Yang may publish in the future.

Co-authorship network of co-authors of Ai‐Hong Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Ai‐Hong Yang. A scholar is included among the top collaborators of Ai‐Hong Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ai‐Hong Yang. Ai‐Hong Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Xu, Zhenghu, Shenshen Yang, Bohan Chen, et al.. (2025). Carrier-free nanoparticles—new strategy of improving druggability of natural products. Journal of Nanobiotechnology. 23(1). 108–108. 13 indexed citations
4.
Yang, Ai‐Hong, et al.. (2025). Potential roles of inhalation aromatherapy on stress-induced depression by inhibiting inflammation in the peripheral olfactory system. Neurochemistry International. 186. 105967–105967. 1 indexed citations
5.
Yang, Ai‐Hong, et al.. (2024). Diosmetin derivatives as multifunctional anti‐AD ligands: Design, synthesis, and biological evaluation. Chemical Biology & Drug Design. 103(4). e14529–e14529. 3 indexed citations
6.
Ji, Yan, et al.. (2024). Photoredox-Catalyzed Difunctionalization of Alkenes with Sulfilimines. Organic Letters. 26(37). 7944–7948. 3 indexed citations
8.
Yang, Ai‐Hong, et al.. (2024). Study of multifunctional anti-AD ligands: design, synthesis, X-ray crystal structure and biological evaluation of diosmetin derivatives. Molecular Diversity. 29(2). 1323–1335. 3 indexed citations
9.
Kou, Xiaodi, et al.. (2023). A coumarin-based multifunctional chemosensor for Cu2+/Al3+ as an AD theranostic agent: Synthesis, X-ray single crystal analysis and activity study. Analytica Chimica Acta. 1279. 341818–341818. 7 indexed citations
11.
Wang, Huiyan, et al.. (2022). Design, Synthesis, Calculation and Biological Activity Studies Based on Privileged Coumarin Derivatives as Multifunctional Anti‐AD Lead Compound. Chemistry & Biodiversity. 20(1). e202200867–e202200867. 7 indexed citations
12.
Yang, Ai‐Hong, et al.. (2022). A multifunctional anti-AD approach: Design, synthesis, X-ray crystal structure, biological evaluation and molecular docking of chrysin derivatives. European Journal of Medicinal Chemistry. 233. 114216–114216. 25 indexed citations
13.
Kou, Xiaodi, et al.. (2022). A multifunctional metal regulator as the potential theranostic agent: Design, synthesis, anti-AD activities and metallic ion sensing properties. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 274. 121110–121110. 5 indexed citations
14.
Yang, Ai‐Hong, Chang Liu, Jiarui Wu, Xiaodi Kou, & Rui Shen. (2021). A review on α-mangostin as a potential multi-target-directed ligand for Alzheimer's disease. European Journal of Pharmacology. 897. 173950–173950. 29 indexed citations
15.
Wu, Jiarui, Xiaodi Kou, Hui Ju, et al.. (2021). Design, synthesis and biological evaluation of naringenin carbamate derivatives as potential multifunctional agents for the treatment of Alzheimer’s disease. Bioorganic & Medicinal Chemistry Letters. 49. 128316–128316. 31 indexed citations
16.
Kou, Xiaodi, Xingying Li, Juanjuan Liu, et al.. (2021). Multifunctional fluorescence sensor as a potential theranostic agent against Alzheimer's disease. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 267(Pt 2). 120587–120587. 11 indexed citations
17.
Yang, Ai‐Hong, Xin He, Jun-Xiu Chen, et al.. (2015). Identification and characterization of reactive metabolites in myristicin-mediated mechanism-based inhibition of CYP1A2. Chemico-Biological Interactions. 237. 133–140. 33 indexed citations
18.
Zhang, Fangliang, Xin He, Sichao Zhang, et al.. (2015). Mechanism-based inhibition of CYPs and RMs-induced hepatoxicity by rutaecarpine. Xenobiotica. 45(11). 978–989. 28 indexed citations
19.
Yang, Ai‐Hong, Fangliang Zhang, Jun-Xiu Chen, et al.. (2014). Reactive metabolite activation by CYP2C19-mediated rhein hepatotoxicity. Xenobiotica. 45(4). 361–372. 49 indexed citations
20.
Zhao, Lihua, et al.. (2011). 3D Metal–Organic Framework Based on Cadmium Complex of Pyrazine-2,3,5,6-tetracarboxylic Acid. Journal of Chemical Crystallography. 41(8). 1245–1248. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026